Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/23/2025

Management of Polymenorrhea

Diagnostic Evaluation

  • The initial approach to managing polymenorrhea should include ruling out underlying gynecological problems, followed by NSAIDs for short-term treatment and hormonal therapy if necessary, as recommended by the Centers for Disease Control and Prevention (CDC) 1, 2
  • First, rule out underlying gynecological problems that may cause polymenorrhea, including pregnancy, sexually transmitted diseases, pathologic uterine conditions, and medication interactions, according to the CDC 1, 2
  • Pathologic uterine conditions, such as polyps or fibroids, should be considered as a potential cause of polymenorrhea, as suggested by the American College of Radiology 1, 3

Treatment Algorithm

First-Line Treatment

  • NSAIDs are recommended for short-term treatment (5-7 days) during days of bleeding, reducing menstrual blood loss, as recommended by the CDC 1, 2
  • Mefenamic acid (500 mg three times daily) is an example of an NSAID that can be used for short-term treatment, according to the CDC 2, 4

Second-Line Treatment

  • If NSAIDs are ineffective or contraindicated, consider hormonal treatment with low-dose combined oral contraceptives (COCs) for short-term treatment (10-20 days), as recommended by the CDC 1, 2

Important Caveats

  • Bleeding irregularities are generally not harmful but can significantly impact quality of life, as noted by the CDC 1, 2
  • Enhanced counseling about expected bleeding patterns has been shown to reduce discontinuation of hormonal contraceptives, according to the CDC 2, 4